SimuGen is a drug discovery pharmacogenomics company focused on predicting human safety earlier.
Seamlessly combine SimuGen's groundbreaking predictive models on your human in vitro data with your current ADMET workflow. Shift from hazard identification to true risk assessment for a wide spectrum of toxicities from day one.

Product Launch SimuGen’s flagship product is due for launch early 2010.

